Delayed Cord Clamping in Infants Born by Cesarean Section
1 other identifier
interventional
80
1 country
1
Brief Summary
Introduction: Placental transfusion supports an important blood transfer to the neonate, promoting a more stable and smooth transition from fetal to extra-uterine life. Cesarean section, especially elective one, reduces the placental transfusion, mainly because of uterine atony. Therefore, during an elective cesarean section umbilical cord management may play a relevant role on blood passage to the neonate and, as consequence, it may affect neonatal hematological values and cardiovascular parameters. The most effective way to manage umbilical cord in in elective cesarean section remains to be established. Objective: The aim of the present study is to evaluate the effect of two different methods of umbilical cord management (Early Cord Clamping - ECC vs. Delayed Cord Clamping - DCC) on the hematocrit on the second day of life; in addition, we will assess the effect on perinatal and postnatal cardiovascular parameters. Material and methods: This is a randomized clinical trial on the effect of different cord management newborns born by cesarean sections. After obtaining parental consent, all mothers \> 38 weeks' gestation will be assigned to eithr ECC or DCC group in a 1:1 ratio according to a computer-generated randomized sequence. The primary outcome will be the hematocrit on day 2 of life. Secondary outcomes will be pre-ductal oxygen saturation (SaO2) and the heart rate (HR) during the first ten minutes after the birth, arterial blood pressures during the first 3 postnatal days and transcutaneous bilirubin (BT) at day 3 after birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 17, 2018
CompletedFirst Submitted
Initial submission to the registry
May 26, 2018
CompletedFirst Posted
Study publicly available on registry
June 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2018
CompletedApril 7, 2020
April 1, 2020
4 months
May 26, 2018
April 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hematocrit
Day 2 of life
Secondary Outcomes (8)
Preductal transcutaneous saturation (TcSaO2)
During the first 10 minutes of life
Heart rate
During the first 10 minutes of life
Arterial blood pressure
At day 1, 2, 3 of life
Total transcutaneous bilirubin
Day 3 of life
Maternal blood losses
At delivery
- +3 more secondary outcomes
Study Arms (2)
Delayed cord clamping (DCC)
EXPERIMENTALCord clamping will be performed after 60 seconds of life
Early cord clamping (ECC)
ACTIVE COMPARATORCord clamping will be performed within 10 seconds of life
Interventions
Cord clamping will be performed after 60 seconds of life in infants delivered by cesarean section
Cord clamping will be performed within 10 seconds of life in infants delivered by cesarean section
Eligibility Criteria
You may qualify if:
- Elective cesarean section
- Gestational age \> or = 39 weeks
- No labor
- Single pregnancy
- Parental consent; a written informed consent will be obtained by a member of the neonatal team involved in the study from a parent or guardian
You may not qualify if:
- Emergent or urgent cesarean sections
- Twin pregnancies
- Parental refusal to participate to the study
- Major congenital malformations (such as cardiopathies)
- Chromosomic abnormalities
- Fetal hydrops
- Severe maternal diseases (such as hypertension)
- Cord abnormalities (length \< 20 cm, funicular prolapse, funicular knots)
- Intrauterine growth restriction (IUGR)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliera di Padova, University of Padova
Padua, 35128, Italy
Related Publications (6)
Wyllie J, Bruinenberg J, Roehr CC, Rudiger M, Trevisanuto D, Urlesberger B. European Resuscitation Council Guidelines for Resuscitation 2015: Section 7. Resuscitation and support of transition of babies at birth. Resuscitation. 2015 Oct;95:249-63. doi: 10.1016/j.resuscitation.2015.07.029. Epub 2015 Oct 15. No abstract available.
PMID: 26477415BACKGROUNDPerlman JM, Wyllie J, Kattwinkel J, Wyckoff MH, Aziz K, Guinsburg R, Kim HS, Liley HG, Mildenhall L, Simon WM, Szyld E, Tamura M, Velaphi S; Neonatal Resuscitation Chapter Collaborators. Part 7: Neonatal Resuscitation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2015 Oct 20;132(16 Suppl 1):S204-41. doi: 10.1161/CIR.0000000000000276. No abstract available.
PMID: 26472855BACKGROUNDKatheria AC, Brown MK, Rich W, Arnell K. Providing a Placental Transfusion in Newborns Who Need Resuscitation. Front Pediatr. 2017 Jan 25;5:1. doi: 10.3389/fped.2017.00001. eCollection 2017.
PMID: 28180126BACKGROUNDZhou YB, Li HT, Zhu LP, Liu JM. Impact of cesarean section on placental transfusion and iron-related hematological indices in term neonates: a systematic review and meta-analysis. Placenta. 2014 Jan;35(1):1-8. doi: 10.1016/j.placenta.2013.10.011. Epub 2013 Nov 20.
PMID: 24290868BACKGROUNDErickson-Owens DA, Mercer JS, Oh W. Umbilical cord milking in term infants delivered by cesarean section: a randomized controlled trial. J Perinatol. 2012 Aug;32(8):580-4. doi: 10.1038/jp.2011.159. Epub 2011 Nov 17.
PMID: 22094494BACKGROUNDFogarty M, Osborn DA, Askie L, Seidler AL, Hunter K, Lui K, Simes J, Tarnow-Mordi W. Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis. Am J Obstet Gynecol. 2018 Jan;218(1):1-18. doi: 10.1016/j.ajog.2017.10.231. Epub 2017 Oct 30.
PMID: 29097178BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniele Trevisanuto, MD
University of Padova, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The health care giver who will perform hematocrit measurement (primary outcome) and the statistician who will perform data analysis will be blind for treatment allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 26, 2018
First Posted
June 8, 2018
Study Start
April 17, 2018
Primary Completion
July 31, 2018
Study Completion
July 31, 2018
Last Updated
April 7, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- July 2018
- Access Criteria
- Contacting PI by e-mail